Abstract
Purpose: Over 65,000 women were diagnosed with endometrial cancer (EC) in 2020. Standard treatment is TAH/BSO with radiation therapy (RT) and chemotherapy given based on risk factors. These can cause significant changes in the vagina, including shortening, narrowing, loss of elasticity, atrophy, and dryness. These complications are not life threatening, but can affect a woman's physical, psychological, and social functioning. Adjuvant vaginal dilator use is often advised, but there are currently inconsistent recommendations on use and no prospective data to support its efficacy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
